Robert Weinstein
CFO, Executive VP, Treasurer & SecretaryMr. Robert Weinstein is Chief Accounting Officer, Principal Financial Officer & Principal Accounting Officer of Petros Pharmaceuticals, Inc. from June 18, 2026. Mr. Weinstein has been an Independent Director at XWELL, Inc. (formerly known as XpresSpa Group, Inc.) since February 3, 2020. He was a Director at Oblong, Inc. since May 2023 until September 10, 2025. He has been an Independent Director at PharmaCyte Biotech, Inc. since November 14, 2022. Mr. Weinstei served as the Chief Financial Officer, Executive Vice President, Secretary and Treasurer of Neurotrope, Inc. He serves as Secretary and Executive Vice President of TAO Synergies Inc. (formerly known as Synaptogenix, Inc.) (formerly, Neurotrope Bioscience, Inc.). Since October 2013, Mr. Weinstein has been the Chief Financial Officer of TAO Synergies Inc. (formerly known as Synaptogenix, Inc.) (formerly Neurotrope Bioscience, Inc.) since June 2013 and has been its Treasurer. He was Interim Chief Financial Officer at Petros Pharmaceuticals, Inc. since December 2020. Mr. Weinstein served as an Independent Consultant at several healthcare companies in the pharmaceutical and biotechnology industries since September 2011 until September 2013. He serves as Corporate Compliance Officer at Neurotrope, Inc. He joined the Neurotrope in June 2013 as its Acting Chief Financial Officer. He has extensive accounting and finance experience, spanning many years as a Public Accountant, Investment Banker, Healthcare Private Equity Fund Principal and as Chief Financial Officer. Mr. Weinstein served as the Chief Financial Officer of Green Energy Management Services Inc. from March 2010 to August 2011. From September 2011 to the present, Mr. Weinstein has also been an independent accounting and finance consultant for several healthcare companies in the pharmaceutical and biotechnology industries. He served as the Chief Financial Officer at Green Energy Management Services Holdings, Inc. from March 2010 to August 2011. Mr. Weinstein is a finance and accounting senior executive of "hands-on" public and private company management, investment banking and private equity investing experience. He is recognized as a relationship savvy, proactive executive officer and principal with a focus on building sustainable shareholder value. He served as the Chief Financial Officer of Xcorporeal, Inc. since August 10, 2007 until February 2010 and served as its Chief Accounting Officer and Secretary. Mr. Weinstein's earlier career roles included Vice President, Director of Quality Control & Compliance at Citi Private Equity Services, Inc.; Chief Financial Officer at Able Laboratories, Inc.; Private Equity Fund Manager at Sanders Morris Harris, Inc.; Managing Director at Gruntal & Company, LLC; and Assistant Vice President, Corporate Finance at GE Capital. He also served as Tax Supervisor for Coopers & Lybrand and Senior Accountant at Berenson, Berenson, Alder & Co. He served as Vice President and Director of Quality Control & Compliance of Citi Private Equity Services. In 2005, he founded and served as Finance & Accounting Consultant of Irvington, NY. He served as Vice President, Treasurer and Principal Accounting Officer of Able Laboratories Inc. from November 2002 to December 29, 2004 and served as its Director of Investor Relations since December 29, 2004. From 2003 to 2004, he served as the Chief Financial Officer of Able Laboratories, Inc. In April 2002, Mr. Weinstein was a Management and Financial Consultant at EB Associates, LLC. Mr. Weinstein founded EB Associates, LLC and served as the Managing Member until December 2002. At EB Associates, he provided financial consulting for Eurotech, Ltd. Since 2002, he served as Acting Chief Financial Officer of Eurotech, Ltd. From April 2001 to April 2002, he served as the Managing Director of Berliner Communications Inc. From August 1998 to April 2001, he served as the Managing Director and manager of a fund investing in micro-cap private and public companies at Sanders Morris Harris Inc. and from March 1992 to August 1998, he served as the Managing Director and Co-Head of Technology Corporate Finance at Gruntal & Company, L.L.C. He is a Certified Public Accountant (inactive) in the State of New York. Mr. Weinstein received an MBA in Finance & International Business from the University of Chicago Graduate School of Business and a B.S. in Accounting with a minor in Economics from the State University of New York at Albany.
Positions
- Company NameTAO Synergies Inc.Stock CodeTAOXPositionCFO, Executive VP, Treasurer & SecretaryColleagues
- JNJoshua N. SilvermanExecutive Chairman of the Board
- RWRobert WeinsteinCFO, Executive VP, Treasurer & Secretary
- AJAlan J. TuchmanChief Medical Officer
- WSWilliam S. SingerIndependent Vice-Chairman of the Board
- BTBruce T. BernsteinIndependent Vice-Chairman of the Board
- GPGeorge PerryChairman of the Scientific Advisory Board
- PCPaul ColemanMember of Scientific Advisory Board
- Company NamePetros Pharmaceuticals, Inc.Stock CodePTPIPositionChief Accounting Officer, Principal Financial Officer & Principal Accounting Officer
- Company NameXWELL, Inc.Stock CodeXWELPositionIndependent DirectorColleagues
- ETEzra T. ErnstPresident & CEO
- BTBruce T. BernsteinIndependent Chairman of the Board
- TIThomas Ian BrownChief Financial Officer
- PWPatti WardChief Operating Officer
- MHMike HeronimeMarketing Director
- PVPeter VermeulenHead of Human Resources
- RWRobert WeinsteinIndependent Director
- MLMichael LebowitzIndependent Director
- GSGaëlle S. WizenbergIndependent Director
- GRGerard ReidDirector
- Company NamePharmaCyte Biotech, Inc.Stock CodePMCBPositionIndependent DirectorColleagues
- JNJoshua N. SilvermanCEO. President & Executive Chairman
- CACarlos A. TrujilloChief Financial Officer
- JLJose L. IglesiasConsulting Chief Medical Officer
- HHHans-Peter HammesMember of Medical & Scientific Advisory Board and Consultant
- MLMatthias LöhrChairman of Medical & Scientific Advisory Board
- JLJonathan L. SchechterIndependent Director
- RWRobert WeinsteinIndependent Director
